Background/Aims: Chloride intracellular channel 1 (CLIC1), which is a member of the chloride channel protein family, is associated with various human tumors. Recent studies have shown that CLIC1 is involved in the occurrence and development of gastric cancer (GC). However, the exact mechanism remains unclear in GC. Methods: Effects of CLIC1 on the progression of GC in vivo and in vitro and the potential underlying mechanisms have been investigated by analysing 54 patients with GC, as well as human gastric cell lines SGC-7901 and MGC-803, utilizing proteomics, RT-PCR, Western blotting, flow cytometry, Cell invasion and migration assays and xenograft tumor models. Results: Our study shows that CLIC1 knockdown by targeted-siRNA markedly inhibits GC cell invasion and migration and induces apoptosis in vitro. In total, 54 differentially expressed proteins were identified in GC cells SGC-7901 after CLIC1 silencing by isobaric tags for relative isotope labeled and absolute quantitation (iTRAQ) technology, including integrin α1 (ITGα1) and ITGα3. The expression levels of ITGα3, ITGαv, ITGβ1 and Bcl-2 mRNA and protein were decreased significantly in GC cells after CLIC1 knockdown; ITGα1 and Fas were upregulated, but the level of survivin was not significantly different. GC growth and metabolism were decreased in vivo after CLIC1 silencing, but apoptosis was markedly increased. Further study showed that the expression levels of ITGα3, ITGαv and ITGβ1, as well as AKT-phosphorylation, ERK-phosphorylation and p38-phosphorylation, were reduced in vivo after CLIC1 knockdown, while ITGα1 was upregulated. Conclusions: We speculate that CLIC1 may play an important role in the progression of GC, and its mechanism may be related to the regulation of integrin family proteins, which leads to the sequential regulation of the PI3K/AKT, MAPK/ERK and MAPK/p38 pathways.
CLIC1 Promotes the Progression of Gastric Cancer by Regulating the MAPK/AKT Pathways

Lentivirus-mediated RNA interference (RNAi)
For lentivirus-mediated silencing of CLIC1 (NM_001288.4), one effective sequence of human CLIC1siRNAs (small interference RNAs) was selected, as follows: 5'-GCCAAAGUUACACAUAGUATT-3'. Another fragment with the scrambled sequence (5'-TTCTCCGAACGTGTCACGT-3') had no significant homology to human and mouse gene sequences and was chosen as a negative control siRNA. These siRNAs were synthesized and inserted into the GV115 lentivirus vector. The positive clones were verified by DNA sequencing. Then, the recombinant lentivirus was packaged and concentrated, and the final virus titer was determined. SGC-7901 and MGC-803 cells were infected with the recombinant lentivirus at a multiplicity of infection of 40 and 10, respectively, for 16h. The medium was then replaced with fresh medium. The cells were observed under fluorescence microscopy after 3 days.
qRT-PCR Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad,CA,USA) according to the manufacturer's instructions. The concentration and purity of the RNA samples were detected at 260 nm. First-strand cDNA was generated through reverse transcription with reverse transcriptase (Promega, Madison, WI, USA). The specific primers were synthesized by Genechem (Shanghai, China) as follows: GAPDH, 5'-TGACTTCAACAGCGACACCCA-3'(forward) and 5'-CACCCTGTTGCTGTAGCCAAA-3'(reverse);CLIC1, 5'-ACCGCAGGTCGAATTGTTC -3'(forward) and 5'-ACGGTGGTAACATTGAAGGTG -3'(reverse); ITGα1, 5'-GTGATAGGAGCTCCGCTGGAA-3' (forward) and 5'-ACATCTGTCAGACCGTCACCATTTA-3'(reverse); ITGα3, 5'-ATTATTGAGGACATGTGGCTTGGAG-3'(forward) and 5'-TGACCACAGCACCTGGGTGTA-3'(reverse); ITGαv, 5'-AAACTCGCCAGGTGGTATGTGA-3'(forward) and 5'-CTGGTGCACACTGAAACGAAGA-3'(reverse); ITGβ1, 5'-AGCTGAAGACTATCCCATTGACCTC-3'(forward) and 5'-TGGTGTTGTGCTAATGTAAGGCATC-3'(reverse). SYBR Premix Ex Taq (TaKaRa, Dalian, China) was used for real-time PCR, and the total reaction volume was 20µl. The cycling conditions included a holding step at 95°C for 30s, and 45 cycles done in two steps: 5 s at 95°C and 30 s at 60°C, and a dissociation step was added to verify that each primer pair produced only a single product at 15 s at 95°C, 30 s at 55°C and 15 s at 95°C. GAPDH was used as the internal control, and gene expression was quantified using the 2 -∆∆Ct method.
iTRAQ (isobaric tag for relative and absolute quantitation) screening of differential proteomics
The cells were harvested for the analysis of protein expression and lysed on ice using RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China). The protein concentration of the lysate was determined by the bicinchoninic acid assay (Beyotime Biotechnology, Shanghai, China). The total protein was digested with Trypsin (Beyotime Biotechnology, Shanghai, China) with the ratio of protein: trypsin =40:1 at 37°C for 16 h. After trypsin digestion, the peptides were dried by vacuum centrifugation. iTRAQ labeling was carried out based on the manufacturer's instructions and each experiment was performed in two biological replicates. The peptides were labeled with the iTRAQ Reagents Multiplex kit (Applied Biosystems, Foster City, CA, USA) and were reconstituted in 70μL ethanol. The control sample and CLIC1siRNA sample were labeled with iTRAQ reagents 114 and 115, respectively. All tagged samples were incubated for 1 h at room temperature and were then pooled together and lyophilized to powder.The labeled samples were purified using a strong cation exchange chromatography (SCX) column (Phenomenex Inc.,Torrance, CA, USA) and separated by liquid chromatography(LC) using the LC-20AB HPLC Pump system.The iTRAQ-labeled peptide mixtures were dissolved in 200μL buffer A [10mM NaH 2 PO 4 in 20% ACN (acetonitrile), pH 3.0] and loaded onto a 100 × 2.1 mm Ultremex SCX column (Phenomenex) containing 5-μm particles. The mobile phase consisted of buffer A, and buffer B (10 mM KH 2 PO 4 , 500 mM KCl, and 20%ACN, pH 3.0) was set at a flow rate of 0.25 ml/ min. An optimized gradient elution mode was carried out as follows: 0-15 min,0%B; 15-50min,0%-40%B; 50-55min, 40%-100%B;55-63min, 100%B; 63-65min, 100%-0% B.Elution was monitored by measuring the absorbance at 214 nm, and fractions were collected every 1 min. The eluted peptides were pooled into 20 fractions, desalted with a Strata X C18 column (Phenomenex Inc.,Torrance, CA, USA) and vacuum-dried [9] .The nanoscale HPLC system (EASY-nLC from Proxeon Biosystems) connected to an Orbitrap Q Exactive equipped with a nanoelectrospray source was used to separate the peptides, and then the peptide samples were loaded onto the EASY C18 column (Thermo Scientific) after reconstituting in mobile phase A (2% ACN and 0.1% formic acid). The liquid phase condition was performed as follows: flow rate of 300nl/min; 0-5min,0%B(98% ACN and 0.1% formic acid); 5-50min,5%-35%B; 50-52min, 35%-100%B;52-55min, 100%B. The effluent from HPLC was directly electrosprayed into the mass spectrometer for analysis [10] , then the SEQUEST Cluster software was used to search the Uniprot (http://www.uniprot.org/), IPI(http:// www.ebi.ac.uk/IPI/) and NCBI (https://www.ncbi.nlm.nih.gov/) databases for differentially expressed proteins.
Western blotting
The protein extraction and concentration determination were similar to the above-mentioned method. Forty micrograms of protein sample per well were resolved by SDS-PAGE and transferred to a PVDF membrane and blocked with 5% BSA (bull serum albumin) in TBST (Tris buffered saline and Tween 20). The membrane was incubated with primary antibodies against Bcl-2(Cell Signaling Technology, Danvers, MA, USA), survivin (Cell Signaling Technology), Fas(Cell Signaling Technology), ITGαv(Abcam, Cambridge, MA, UK), ITGα1 (Abcam), ITGα3(Abcam), ITGβ1(Abcam) and β-actin(Cell Signaling Technology) and were then incubated with HRP-conjugated secondary antibody (Cell Signaling Technology). Immunoreactivity signals were developed using the ECL reagent (Beyotime Biotechnology) and recorded by a fluorescence detection system.
Cell apoptosis analysis
An annexin V-PE Apoptosis Detection Kit (Becton Dickinson, San Diego, CA, USA) was used to detect cell apoptosis following the manufacturer's instructions. In brief, the cells were collected by centrifugation at 2000 rpm for 5 min. After washing, the cells were resuspended in 100μlof annexin V binding buffer, then 5μl annexin V-PE and 5μl 7-Amino-actinomycin D were added to the solution. After incubation in the dark for 15 min at room temperature, 400μlof binding buffer was added, and the cells were subjected to flow cytometry (FCM).
Cell invasion and migration assay
The invasive capacity of the cells after transfection was measured using a Transwell chamber assay. Matrigel (Becton Dickinson) was put into a 4°C refrigerator overnight to melt. The next day, the Matrigel concentration was diluted by 1.25mg/ml with serum-free medium, and 50μl Matrigel was added to the upper chamber of each Transwell insert (pore size 8μm, Corning, NY, USA). Next, they were incubated at 37°C for 5 h to convert the Matrigel from liquid to gelatin. After hydration of the Matrigel with serum-free medium, 100μl SGC-7901 and MGC-803 cells with a density of 3×10 5 /ml and 2×10 5 /ml, respectively, were placed in the upper chamber of each Transwell insert, and 500μl of RPMI 1640 supplemented with 10% fetal bovine serum was added to the lower compartment of the cell culture insert.After a 24-h incubation at 37°C in 5% CO 2 , the cells on the upper surface of the Transwell insert were completely removed by wiping with a cotton swab. The invaded cells that remained on the lower surface of the filter were fixed and stained with 1% crystal violet (Sigma-Aldrich, USA) solution and 10% ethanol. The stained cells in five randomly selected microscopic fields per filter were counted. A cell migration assay was also performed using a Transwell chamber assay (pore size 8μm, Corning,NY, USA) without Matrigel. Other treatments were the same as the cell invasion assay.
Orthotopic xenografted tumor models
The animal experimentswere approved by the Animal Ethics Committee of The First Affiliated Hospital of Guangxi Medical University. Female BALB/C nude mice (5-6 weeks old, weighing about 18-20g) were housed in an animal facility with 50%-65% relative humidity, 22°C-24°C environmental temperatureand a 12-h light/dark cycle. The BALB/C nude mice were randomly divided into threegroups (n = 6/group). Then, CLIC1 knockdown or siRNA control SGC-7901 and MGC-803 cells (6×10 7 in 200μl medium) were injected subcutaneously into the armpit area. However, the MGC-803-KD xenografted tumor model failed even when the experimental conditions were optimized. Through a literature search, we found that an siRNA with a special chemical modification (chol-siRNA) can be directly injected into specific tissues or organs to silence a target gene [11] . Thus, both CLIC1-chol-siRNA and MGC-803 cells were injected subcutaneously into the armpit area, and MGC-803-chol subcutaneous tumors were successfully established. The subcutaneous tumors were sliced and inoculated in the armpit area again. Then, the subcutaneous tumors of the second generation were sliced for constructing orthotopically transplanted tumors. The tumor volume was calculated by 0.5×length ×width 
Statistical analysis
All experiments were performed at least in triplicate.The datais expressed as mean ± SD(standard deviation). Differences among the means of multiple groups were compared using analysis of variance (ANOVA). The t test was used to compare the difference between two groups. Statistical significance was determined at P< 0.05.
Results
Association of CLIC1 expression with clinicopathological characteristics
Representative staining results of CLIC1 are presented in Fig. 1A -B, which show the expression of the protein in the cytoplasm and nucleus. The results show that CLIC1 staining in GC was higher than that of adjacent noncancerous tissue (P<0.001) (Fig. 1C) . Clinicopathological characteristics including patient sex, age, whether lymph node metastasis occurred, whether distant metastasis occurred, pathological type and TNM stage of the patients enrolled in this study are listed in Table 1 . As shown,a higher CLIC1 positive rate was observed in patients with distant metastasis than in those without metastasis (P<0.001). Moreover, higher CLIC1 expression was observed in patients with the worst TNM stage (P =0.028).
GC cell lines with low CLIC1 expression were constructed
The CLIC1-siRNA sequence was successfully inserted into the GV115 lentivirus vector and the positive clones were verified by DNA sequencing (Fig. 2A) . The cell transfection was performed by lentivirus-mediated RNAi. The transfection efficiency was evaluated under a fluorescence microscope. Our results showed that the transfection efficiency was over 80% in both SGC-7901 and MGC-803 cells (Fig. 2B-C) . The CLIC1 mRNA expression in SGC-7901 and MGC-803 cells was significantly lower than that in the negative control (NC) and blank control (CON) groups after lentivirus-mediated RNAi (P<0.05).The inhibition rate was over 85% in both SGC-7901 and MGC-803 cells ( Fig. 2D-E) .
CLIC1 inhibits apoptosis of GC in vitro
Apoptosis was detected using FCM. The apoptosis rate of the knock down (KD) group was significantly higher than that of the CON group in SGC-7901 (25.52% vs 12.67%, P<0.05) and 
Protein mass spectrometry analysis of GC cells SGC-7901 after CLIC1 silencing
We set the protein content ratio of SGC-7901 and SGC-7901-KD more than 2.0 or less than 0.5 as differentially expressed proteins, and then we used SEQUEST Cluster software to search the Uniprot, IPI and NCBI data bases. The results revealed that there were 36 upregulated and 18 down-regulated differentially expressed proteins from the SGC-7901 and SGC-7901-KD groups after CLIC1 silencing, including two ITGs, ITGα1 and ITGα3 (Tables 2 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry ' "'
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry and 3). Then, we submitted integrin genes, CLIC1 and MAPK family genes into geneMANIA (http://genemania.org/) for signal pathway prediction to explore whether CLIC1 is associated with integrins and the MAPK signaling pathway. The results showed thatCLIC1, ITGαv, ITGα1, ITGα3, ITGβ1, EKR, AKT1 and p38 are in the same signal network (Fig.5 ), which suggests there may be regulatory relationships among them. We performed protein mass spectrometry analysis in one of the GC cell lines, and the above hypothesis was confirmed in the following experiments in both of the SGC-7901 and MGC-803 cell lines.
CLIC1 silencing affected the expressions of ITGs
Our study showed that the CLIC1 mRNA expression was significantly inhibited in both KD groups of SGC-7901 and MGC-803 cells (P<0.05). CLIC1 silencing significantly increased ITGα1 mRNA expression, but inhibited the expression of ITGα3, ITGαv and ITGβ1 mRNA (P<0.05) (Fig. 6A-B) . Western blot assays also displayed similar findings (Fig. 6C-D) .
CLIC1 silencing inhibited the subcutaneous tumor growth of GC
The subcutaneous tumors of the original generation were successfully constructed in the SGC-7901,SGC-7901-NC,SGC-7901-KD,MGC-803 and MGC-803-NC groups in about 2-3 weeks in BALB/C nude mice, but failed in the MGC-803-KD group (Fig. 7A-B) .The subcutaneous tumor growth of the original generation of the SGC-7901-KD group was significantly inhibited after CLIC1 silencing (P<0.05) (Fig. 7A) .Finally, the CLIC1 silencing group (MGC-803-chol) and its negative control group (MGC-803-NC1) were successfully established as subcutaneous tumors of the original generation after using siRNA by special chemical modification (chol-siRNA).We found that the tumor growth of the MGC-803-chol group was slower than the MGC-803-NC1 group (P<0.05) (Fig. 7C) . Compared with the corresponding control group, the subcutaneous tumor growth of second generation was significantly inhibited in the SGC-7901-KD and the MGC-803-chol groups (P<0.05) (Fig.  7D-E) . After HE staining, the subcutaneous tumor tissues that had cells with irregular arrangements, varied sizes, large nuclei that were deeply stained, an increased nucleoplasm ratio, obvious nuclear atypia and pathologic mitosis were verified as GC cells (Fig. 7F-G) . 
Orthotopically transplanted GC tumors were successfully established The mice were sacrificed after feeding for several weeks. The orthotopically transplanted GC tumors were successfully constructed, and the tumor volume and mass of theSGC-7901-KD and MGC-803-chol groups were significantly lower than those of the corresponding The cell migration assay showed that the number of SGC-7901 and MGC-803 cells crossing the basement membrane significantly decreased after CLIC1-siRNA3 transfection (*P<0.05 vs blank control and negative control groups). The cell invasion assay showed that the number of SGC-7901 and MGC-803 cells crossing the basement membrane markedly decreased after CLIC1-siRNA3 transfection (*P<0.05 vs blank control and negative control groups). (Fig. 8A-F) . The CLIC1 protein expression detected by WES technology was significantly reduced in the SGC-7901-KD and MGC-803-chol groups (Fig. 8G-I) .
CLIC1 inhibited the apoptosis of orthotopically transplanted GC tumors
The apoptosis of orthotopically transplanted GC tumors was detected using TUNEL by DAB and fluorescence staining. The apoptosis rate after CLIC1 silencing was significantly higher than that of the CON group in SGC-7901 and MGC-803 cells (21.92% vs 2.12% and 26.50% vs 3.35%, respectively, P<0.05) (Fig. 9A) . When fluorescence staining was used, the apoptosis rate was similar to that measured by DAB staining (P<0.05) (Fig.  9B) . We further detected the CLIC1 silencing significantly increasedITGα1 mRNA expression, but inhibited the ITGα3, ITGαvandITGβ1 mRNA expression levels (*P<0.05 vs blank control and negative control groups) in SGC-7901 and MGC-803 cells (A-B). The protein expression levels were similar to the mRNA levels (D-E) (*P<0.05 vs blank control and negative control groups).
• coN CJ NC -KO Metabolic rate of the orthotopically transplantated tumors was reduced after CLIC1 silencing Compared with the corresponding control group, PET-CT showed that the metabolic rate of the orthotopically transplanted tumors was significantly reduced in the SGC-7901-KD and MGC-803-chol groups (P<0.05), but distant metastasis was not observed in any of the groups (Fig. 10A-D) .
CLIC1 silencing affected the relative protein expression levels of ITGs and signaling pathways
WES technology showed that the protein expression of ITGα1 was increased, but ITGα3, ITGα5, ITGαv and ITGβ1 were down-regulated in orthotopically transplanted tumors of the SGC-7901-KD and MGC-803-chol groups after CLIC1 silencing (P<0.05) (Fig. 11A-B) . Moreover, down-regulating CLIC1 also affected the expression levels of signaling pathway proteins. Our results showed that the protein expression levels of p-ERK and p-AKT in orthotopically transplantated tumors from the SGC-7901-KD and MGC-803-chol groups after CLIC1 silencing were significantly lower than those of the control groups (P<0.05), but the expression level of p-p38 was increased (P<0.05). The expression levels of ERK, AKT and p38 were similar to those of the control groups (P>0.05) (Fig. 11A&C) . 
Discussion
Our results show that CLIC1 silencing promoted GC cell apoptosis and inhibited migration and invasion in vitro. Moreover, inhibiting CLIC1 affected the expression of ITGs at both the mRNA and protein levels. Furthermore, we demonstrated that in vivo CLIC1 has a similar function, as CLIC1 knockdown suppressed orthotopic xenograft tumor volume, weight, metabolism and lymphatic infiltration capacity, and promoted apoptosis. Additionally, inhibiting CLIC1 not only effectively affected the expression of protein of ITGs, but also influenced AKT and MAPK pathways in orthotopically xenografted tumors in nude mice models.
CLIC1 is an intracellular ion channel that is involved in many important physiological processes in the body [3] . At present, CLIC1 has been found to be closely related to many kinds of tumors. Several studies have shown that CLIC1 is expressed at a low level in normal gastric tissues and highly expressed in GC tissues [14] [15] [16] . It has also been found that the expression of CLIC1 in GC is closely related to the invasion and metastasis of lymph nodes and the infiltration of peripheral nerves, suggesting that CLIC1 is a potential tumor marker [7] . In this study, we successfully established a recombinant lentiviral expression vector targeting CLIC1 using RNAi, and then we established stable GC cell lines with low CLIC1 expression. The inhibition rate of CLIC1 in the GC lines SGC-7901-KD and MGC-803-KD was 89.3% and 93.8%, respectively, which provides a stable vector for further study of the relationship between GC and CLIC1.
Studies have confirmed that CLIC1 is involved in the apoptosis of tumor cells. Kang et al. [17] showed that inhibiting the expression of CLIC1 in glioma stem cells promoted the apoptosis of tumor cells. Our results showed that the apoptosis rate of GC cells after knockdown of CLIC1 significantly increased, suggesting that CLIC1 silencing is able to promote the apoptosis of GC cells. In addition, we measured the expression of apoptosisrelated proteins (Bcl-2 and survivin) to elucidate the anti-apoptotic mechanisms of CLIC1 in each group. Notably, the expression levels of these two proteins were the same after CLIC1 silencing. In the silenced groups, Bcl-2 expression decreased while survivin expression remained unchanged.
Migration and invasion are the basic processes of metastasis in malignant tumor cells. Reports have shown that CLIC1 silencing significantly decreased the migration and invasion of [5, 6] , while CLIC1 over-expression markedly increased the migration and invasion of hepatocellular carcinoma cells [18] . Our results show that the migration and invasion of SGC-7901KD and MGC-803KD cells significantly decreased after inhibition of CLIC1 expression, which is consistent with the results of previous studies.
The mechanism of how CLIC1 is involved in apoptosis, invasion and metastasis of GC cells remains unclear. ITGs play an important role in the apoptosis, invasion and metastasis of GC [19, 20] . It is possible that CLIC1 interacts with ITGs to regulate the progression of GC. In order to verify this hypothesis, we used iTRAQ technology to analyze the differentially expressed proteins of SGC-7901 GC cells before and after inhibiting the expression of CLIC1 [21] . We found that ITGs were differentially expressed, and verification experiments showed that . Figure 10 the expression of ITGα3, ITGαv and ITGβ1 in the two GC cell lines were downregulated at both the mRNA and protein level, but the expression of ITGα1 was up-regulated. Other studies have investigated the level of ITGs in various tumors. Tanaka and Fukuzawa [22] found that the invasiveness of human neuroblastoma cells was inhibited by up-regulating ITGα1. Additionally, Nakada et al. [23] reported that ITGα3 is over-expressed in glioma stem-like cells and promotes invasion.
Furthermore, evidence shows that overexpression of ITGαv is closely associated with the metastasis and progression of some cancers [24, 25] .
Specifically, Yim et al. [26] showed that ITGα1 was significantly associated with the occurrence of GC. In addition, Fukuda et al. [20] found that ITGα1 was highly expressed in GC cells, and using a specific blocking agent, the adhesion of GC cells decreased significantly. In this study, we found that ITGα1 was over-expressed, and migration and invasion was inhibited, results that are corroborated by the findings of Fukuda et al.
Studies have found that ITGα3 is an important component of the receptors of the basement membrane, which is also involved in the reorganization of the cytoskeleton, and mediates the movement of GC cells to distant metastasis. Moreover, there is a positive correlation between ITGα3 and tumor TNM stage and lymph node metastasis [27] . Combined with the down-regulation of ITGα3 in our study, GC cells appear to infiltrate the basement membrane and degrade the extracellular matrix, leading to the inhibition of distant metastasis, which is consistent with our results. ITGαv is over-expressed in human GC tissue and is associated with the five year survival rate of GC patients [28] . Additionally, studies have indicated that ITGαv affects lymph node metastasis and the formation of MMP-9, which could directly provide the driving force for cell migration, especially the migration of cancer cells through endocytosis exocytosis cycle [29, 30] . Combined with the down-regulation of ITGαv in our study, we speculate that this could lead to the decrease in invasion and metastasis of GC cells. ITGβ1 may be an independent prognostic factor for GC patients. It promotes angiogenesis, lymph node metastasis and Fig. 11 . The relative protein expression levels of integrins and signaling pathways after CLIC1 silencing in vivo by WES technology. In the SGC-7901 and MGC-803 groups, the protein expression of ITGα1 was increased, but the integrins ITGα3, ITGα5, ITGαv and ITGβ1 were down-regulated in orthotopically transplanted tumors after CLIC1 silencing(*P<0.05) (A-B). In the SGC-7901 and MGC-803 groups, the protein expression levels of p-ERK and p-AKT in orthotopically transplanted tumors after CLIC1 silencing were significantly lower than those of the control groups, but p-p38 was increased(*P<0.05) and the ERK, AKT and p38 levels were similar to those of the control groups (P＞0.05) (A and C). Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry vascular invasion, which often indicates poor prognosis [31] . Inhibition of the expression of ITGβ1 inhibited the peritoneal metastasis of GC cells [32] . In the present study, the downregulation of ITGβ1 was accompanied with a decreased in the metastasis of GC cells, similar to the aforementioned findings. Thus, CLIC1 gene silencing affects the progression of GC cells in vitro by regulating the expression of ITGα1, ITGα3, ITGαv and ITGβ1. Our in vitro results showing the effect of CLIC1 in GC cell lines prompted us to create an in vivo model of subcutaneous GC growth in BALB/c mice. We found that CLIC1 knockdown suppressed orthotopic xenograft tumor volume, weight, metabolism and lymphatic infiltration capacity, but promoted apoptosis. Given that GC metastasis is the leading cause of GC related death, our observations may lead to important clinical developments. The effectiveness of CLIC1 in vitro has been described predominantly in cell lines, and these results are supported by Setti et al. [6, 17, 33] . Our data demonstrates the effectiveness of CLIC1 in clinically relevant GC models. However, the mechanism of how CLIC1 affects apoptosis, metabolism and metastasis in GC is not clear.
Based on the observation that CLIC1 promoted the apoptosis of human GC cells accompanied by down-regulation of the apoptotic protein BCL-2, we detected the expression levels of Bcl-2 and Bax in orthotopic xenograft tumor tissue. Bax is a homologous protein of Bcl-2, which promotes apoptosis. Bax and Bcl-2 can form an apoptotic regulatory system [34] . The results showed that Bcl-2 is down-regulated and Bax is up-regulated. Additionally, the inhibitory effect of CLIC1 on ITGs has been described in GC cell lines in vitro, and our research shows that ITGα3, ITGαv and ITGβ1 were down-regulated, but ITGα1 was upregulated, consistent with what we observed in vitro. Hence, CLIC1 acts as a regulator of ITGs. On the other hand, ITGs may influence MAPK and AKT signaling in tumors [35] [36] [37] . Thus, we measured the expression of PI3K/Akt, MAPK/ERK, MAPK/p38 and MAPK/JNK in orthotopically xenografted tumors. The results showed that p-AKT and p-ERK were downregulated, p-p38 was up-regulated and p-JNK was not expressed. Therefore, we propose the following as the molecular mechanism of CLIC1 regulation. First, the formation of a Bax homodimer (Bax-Bax) induces cell apoptosis, and when Bcl-2 is highly expressed, the more stable heterodimer (Bcl-2-Bax) is formed, which suppresses apoptosis. According to our results, with the silencing of CLIC1, Bax was overexpressed, while Bcl-2 was downregulated in orthotopically transplanted tumors. We observed that relatively more Bax-Bax homodimers induced apoptosis. The phosphorylation of ERK is crucial for the activation of the MAPK/ERK pathway ,and it was associated with apoptosis, metastasis of tumors [38, 39] . On the other hand, the phosphorylation of AKT is also crucial for the activation of the PI3K/AKT pathway, and it was associated with apoptosis, angiogenesis of tumors [40, 41] . We observed that CLIC1 blocked ERK-phosphorylation and AKT-phosphorylation, and both had reduced levels in orthotopically xenografted tumors. Studies have shown that ITGαv may be involved in the regulation of the MAPK/ERK and PI3K/AKT pathways, affecting tumor apoptosis and metastasis [40, 42] . In our study, the expression of ITGαv was downregulated, while at the same time, ERK-phosphorylation and AKT-phosphorylation were down-regulated after silencing CLIC1. This suggests that interference with the MAPK/ERK and PI3K/AKT pathways might be responsible for the pro-apoptotic and metastatic effects of CLIC1 induced by ITGαv in orthotopically xenografted GC tumors. In addition, ITGα3 was over-expressed in glioma stem-like cells and promoted invasion via MAPK/ERK [23] . The MAPK/p38 pathway is mainly associated with inflammation, stress and apoptosis, which are involved in the occurrence and development of GC by p38-phosphorylation activation in gastric epithelial cells [43, 44] . When the level of p38 phosphorylation is increased, the apoptosis of GC cells increases [45] . In our study, p38-phosphorylation was increased, and the apoptosis of orthotopically xenografted tumors also increased.
There are some limitations to our study, which we plan to address in the future. First, we only used iTRAQ to screen the differential proteomics of the SGC-7901 GC cell line. Second, the mechanism of the interaction between CLIC1 and ITGs protein family is unclear. 
Conclusion
Our finds showed that siRNA-mediated down-regulation of CLIC1 expression can effectively inhibit the migration and invasion of GC in vitro and in vivo, promote apoptosis and alter the expression ITG family proteins (including ITGα1, ITGα3, ITGαv and ITGβ1) to different extents. Additionally, it regulates signaling pathway cascades. Thus, CLIC1 may play an important role in the progression of GC, and its mechanism may affect the expression of ITG family proteins, which leads to the subsequent regulation of the PI3K/AKT, MAPK/ERK and MAPK/p38 pathways.
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